COMMUNIQUÉS West-GlobeNewswire

Rakovina Therapeutics to Present New Data Highlighting CNS-Penetrant ATR and PARP1 Inhibitors at the 2025 Society for Neuro-Oncology Annual Meeting
10/11/2025
VANCOUVER, British Columbia, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV)(FSE: 7JO0) a biopharmaceutical company advancing cancer therapies through AI-enabled [...]
Idorsia’s aprocitentan improved key prognostic indicators in patients with difficult-to-control hypertension
10/11/2025
New analysis from landmark Phase 3 PRECISION trial published in the Journal of Hypertension highlights aprocitentan led to improvements in dipping pattern and BP load Findings reinforce the role of aprocitentan’s novel [...]
HHS Advances Women’s Health, Removes Misleading FDA Warnings on Hormone Replacement Therapy
10/11/2025
Washington, D.C., Nov. 10, 2025 (GLOBE NEWSWIRE) -- The U.S. Department of Health and Human Services (HHS) today announced historic action to restore gold-standard science to women’s health. After more than two decades [...]
Glaucoma 360 2026: Where Science, Innovation, and Collaboration Shape the Future of Vision
10/11/2025
Annual event accelerates progress toward curing glaucoma, from groundbreaking research to emerging therapies SAN FRANCISCO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Glaucoma Research Foundation (GRF) today announced the 15th [...]
NTG Nordic Transport Group publishes interim report for Q3 2025
10/11/2025
Company announcement no. 10 – 25 10 November 2025 NTG Nordic Transport Group publishes interim report for Q3 2025 The interim report for Q3 2025 is enclosed. In connection with publication of the results for Q3 2025, a [...]
Genmab Provides Certain Information Disclosed in Connection with Proposed Private Offering of Senior Secured Notes and Senior Unsecured Notes
10/11/2025
Media Release COPENHAGEN, Denmark; November 10, 2025 Genmab A/S (“Genmab”) announced on November 10, 2025, that it and its wholly owned subsidiary Genmab Finance LLC intend to offer, subject to market and other [...]
Booking Health Announces Expanded Access to Stage 4 Lung Cancer Treatments During Lung Cancer Awareness Month
10/11/2025
Stage 4 Lung Cancer Langenfeld, Germany, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Booking Health , a global facilitator of international medical care, announced today a timely initiative aimed at improving access to advanced [...]
ACTG Presents SLIM LIVER Findings at AASLD Liver Meeting Demonstrating Improvements in Biomarkers of Cardiovascular Risk among People Living with HIV and MASLD Who Receive Semaglutide
10/11/2025
LOS ANGELES, Nov. 10, 2025 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced data finding that treating people living with HIV and metabolic [...]
Booking Health Launches Initiative to Improve Global Access to Stage 4 Pancreatic Cancer Treatment
10/11/2025
Stage 4 Pancreatic Cancer Langenfeld, Germany, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Booking Health , a leading international medical tourism platform, announced today the expansion of its global patient support services [...]
HFMA report: Healthcare C-suite executives feel underprepared for the future, especially when it comes to AI deployment
10/11/2025
CHICAGO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- In the current environment of unsustainable costs and rapid technological advancement, top U.S. health system leaders say old ways of doing business in healthcare are no longer [...]
Baylor Genetics Launches Pharmacogenomic and Germline Genetic Testing for the U.S. Department of Veterans Affairs
10/11/2025
The initiative ensures veterans of the Armed Services will have access to comprehensive pharmacogenomic and germline genetic testing* HOUSTON, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Baylor Genetics , a clinical diagnostic [...]
Largest Real-World Study of Wearable Defibrillators Confirms Strong Effectiveness and Safety Performance of Kestra’s ASSURE Device
10/11/2025
KIRKLAND, Wash., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today announced primary results from the ASSURE ® WCD [...]
Novartis opens new radioligand therapy manufacturing facility in California as part of $23B US expansion plan
10/11/2025
Carlsbad location is company’s third US-based radioligand therapy (RLT) manufacturing site New site expands manufacturing footprint to meet future demand; ensures continued on-time delivery rate of >99.9% to patients [...]
Olympia Pharmaceuticals Launches OlympiaGO: A Convenient Hydration Drink Mix for Immune Support and Wellness
10/11/2025
New product line offers three refreshing flavors designed to boost hydration, energy, and immunity, all while supporting a healthy lifestyle with no added sugars or artificial ingredients ORLANDO, Fla., Nov. 10, 2025 ( [...]
JenaValve‘s Trilogy™ System Featured in Live Procedure at TCT 2025
10/11/2025
IRVINE, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced highlights from the 2025 Transcatheter [...]
Codexis Announces Signing of Lease for GMP Manufacturing Facility
10/11/2025
REDWOOD CITY, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today announced that [...]
IRADIMED CORPORATION Named to TIME's List of America's Growth Leaders for 2026
10/11/2025
Recognized for Exceptional Revenue Growth, Financial Stability, and Stock Performance ORLANDO, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in developing innovative magnetic [...]
Cadrenal Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
10/11/2025
PONTE VEDRA, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome current gaps in anticoagulation therapy, [...]
Evosep Unveils Open Innovation Initiative to Expand Standardization in Proteomics
10/11/2025
TORONTO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- HUPO World Congress – Evosep, a global leader in proteomics solutions, is proud to announce a new initiative at HUPO 2025 aimed at solving one of LCMS based proteomics most [...]

Pages